BNP Paribas Financial Markets’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,386
Closed -$390K 5898
2025
Q4
$390K Buy
25,386
+4,316
+20% +$47.5K ﹤0.01% 3703
2025
Q3
$209K Sell
21,070
-879
-4% -$9.15K ﹤0.01% 3994
2025
Q2
$218K Sell
21,949
-254,016
-92% -$2.68M ﹤0.01% 3744
2025
Q1
$3.58M Buy
275,965
+121,092
+78% +$1.6M ﹤0.01% 2007
2024
Q4
$1.98M Buy
154,873
+122,136
+373% +$1.48M ﹤0.01% 2372
2024
Q3
$365K Sell
32,737
-27,270
-45% -$301K ﹤0.01% 2982
2024
Q2
$674K Sell
60,007
-242,465
-80% -$2.82M ﹤0.01% 2498
2024
Q1
$3.75M Sell
302,472
-110,937
-27% -$1.45M ﹤0.01% 1644
2023
Q4
$5.78M Buy
413,409
+78,824
+24% +$1.09M 0.01% 1318
2023
Q3
$4.94M Sell
334,585
-176,256
-35% -$2.48M 0.01% 1279
2023
Q2
$6.6M Sell
510,841
-128,347
-20% -$1.46M 0.01% 1094
2023
Q1
$6.27M Buy
639,188
+89,235
+16% +$953K 0.01% 1128
2022
Q4
$5.85M Sell
549,953
-115,683
-17% -$1.34M 0.01% 1231
2022
Q3
$6.95M Buy
665,636
+634,475
+2,036% +$8.27M 0.01% 1193
2022
Q2
$392K Sell
31,161
-45,588
-59% -$484K ﹤0.01% 2781
2022
Q1
$832K Sell
76,749
-179,582
-70% -$2.18M ﹤0.01% 2438
2021
Q4
$3.61M Buy
256,331
+237,140
+1,236% +$3.9M 0.01% 1573
2021
Q3
$369K Buy
19,191
+15,400
+406% +$205K ﹤0.01% 2864
2021
Q2
$37.3K Sell
3,791
-12,732
-77% -$116K ﹤0.01% 3371
2021
Q1
$162K Buy
16,523
+4,972
+43% +$41K ﹤0.01% 3136
2020
Q4
$51.4K Sell
11,551
-13,665
-54% -$61.9K ﹤0.01% 3544
2020
Q3
$109K Buy
25,216
+13,320
+112% +$95K ﹤0.01% 3073
2020
Q2
$106K Sell
11,896
-33,128
-74% -$167K ﹤0.01% 2745
2020
Q1
$159K Buy
45,024
+31,955
+245% +$148K ﹤0.01% 2970
2019
Q4
$74.8K Buy
13,069
+733
+6% +$3.92K ﹤0.01% 3439
2019
Q3
$44.1K Buy
12,336
+4,680
+61% +$18.1K ﹤0.01% 3548
2019
Q2
$30.5K Sell
7,656
-5,322
-41% -$30.9K ﹤0.01% 3724
2019
Q1
$94.9K Buy
12,978
+12,955
+56,326% +$127K ﹤0.01% 3155
2018
Q4
$210 Sell
23
-2,038
-99% -$22.6K ﹤0.01% 4096
2018
Q3
$25.6K Hold
2,061
﹤0.01% 3314
2018
Q2
$31.4K Sell
2,061
-10,904
-84% -$188K ﹤0.01% 3314
2018
Q1
$257K Buy
12,965
+245
+2% +$4.23K ﹤0.01% 2650
2017
Q4
$238K Buy
12,720
+6,581
+107% +$132K ﹤0.01% 2877
2017
Q3
$132K Buy
6,139
+1,083
+21% +$17.1K ﹤0.01% 2652
2017
Q2
$48.8K Buy
5,056
+4,827
+2,108% +$31.3K ﹤0.01% 3205
2017
Q1
$1.36K Sell
229
-434
-65% -$2.09K ﹤0.01% 3636
2016
Q4
$2.62K Sell
663
-2,160
-77% -$15.8K ﹤0.01% 3873
2016
Q3
$29.6K Buy
2,823
+1,192
+73% +$17.1K ﹤0.01% 2679
2016
Q2
$23.8K Buy
+1,631
New +$27.9K ﹤0.01% 2519
2016
Q1
Sell
-8,288
Closed -$200K 2782
2015
Q4
$200K Buy
8,288
+256
+3% +$6.41K ﹤0.01% 1923
2015
Q3
$197K Buy
8,032
+5,594
+229% +$158K ﹤0.01% 1962
2015
Q2
$57.1K Buy
2,438
+1,818
+293% +$39.6K ﹤0.01% 2418
2015
Q1
$13.9K Buy
+620
New +$11.9K ﹤0.01% 2559
2014
Q4
Sell
-1,548
Closed -$22.1K 2302
2014
Q3
$22.1K Buy
1,548
+1,404
+975% +$20.2K ﹤0.01% 3105
2014
Q2
$2.31K Buy
+144
New +$2.17K ﹤0.01% 3021
2014
Q1
Sell
-333
Closed -$6.52K 3497
2013
Q4
$6.52K Sell
333
-4,658
-93% -$68.2K ﹤0.01% 2923
2013
Q3
$59.4K Sell
4,991
-1,445
-22% -$18.2K ﹤0.01% 2492
2013
Q2
$70.8K Buy
+6,436
New +$136K ﹤0.01% 2605

Other funds holding DVAX

BNP Paribas Financial Markets's DVAX Position: Q1 2026 in Review

BNP Paribas Financial Markets sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 25,386 shares — an estimated $390K sold.

BNP Paribas Financial Markets first reported a position in DVAX in Q2 2013 and held it in 48 quarters. The position peaked at $6.95M in Q3 2022. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • BNP Paribas Financial Markets reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 25,386 Dynavax Technologies shares in Q1 2026, an estimated $390K.
  • BNP Paribas Financial Markets first reported a position in Dynavax Technologies in Q2 2013 and held it in 48 quarters.
  • BNP Paribas Financial Markets's Dynavax Technologies position peaked at $6.95M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.